list : COVID-19
-
The pandemic turns 2
Stanford Medicine scientists explain what we know, and what we don’t know, about living with COVID-19 two years after the World Health Organization declared a pandemic.
-
Lab processes 1 millionth COVID-19 test
Stanford Medicine’s clinical virology laboratory has processed its 1 millionth COVID-19 test nearly two years after becoming one of the first academic center testing sites in the country.
-
Vaccination protects better than infection
COVID-19 vaccines are better than infection at making antibodies to recognize new viral variants, according to a Stanford study.
-
Cancer drug renders COVID vaccine ineffective
Rituximab, a drug widely used in patients with lymphoma, blunts or eliminates the antibody response to COVID-19 vaccines if it is administered before them, Stanford researchers say.
-
Antibodies may predict COVID-19 severity
A look at antibodies in patients soon after they were infected with the virus that causes COVID-19 showed key differences between those whose cases remained mild and those who later developed severe symptoms.
-
Grant for faculty family care
The Doris Duke foundation has awarded the Stanford School of Medicine $550,000 to aid physician-scientists with family caregiving responsibilities heightened by COVID-19.
-
Surgery rates rebounded quickly in pandemic
After a dramatic drop in nonessential surgery rates early in the pandemic, U.S. hospitals quickly adapted to new safety protocols, and rates returned to normal, Stanford Medicine research shows.
-
Study: COVID-19 vaccine effective in cancer patients
The Moderna and Pfizer BioNTech vaccines prevented COVID-19 infection in cancer patients, particularly in those whose treatment concluded more than six months before vaccination, say researchers at Stanford, Harvard and the VA.
-
Experts: Pandemic sparked key innovations
In the final installment of The Pandemic Puzzle: Lessons from COVID-19, leaders in government, academia, health care and business said biomedical and digital health advances of the last few years will help combat future health crises.
-
Researchers to study long COVID
Data suggest that between 10% and 30% of those who have had an acute SARS-CoV-2 infection will experience the persistent pattern of symptoms known as long COVID.